Design, synthesis, and evaluation of a liposaccharide drug delivery agent: application to the gastrointestinal absorption of gentamicin.
D000818:Animals; D001682:Biological Availability; D015195:Drug Design; D004386:Duodenum / Q000378:metabolism / Q000473:pathology / Q000502:physiology; D004947:Esophagus / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D005079:Excipients / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D005839:Gentamicins / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005965:Glucuronates / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D006017:Glycolipids / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D007408:Intestinal Absorption / Q000187:drug effects*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008070:Lipopolysaccharides / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D008297:Male; D008823:Micelles; D051381:Rats; D017207:Rats, Sprague-Dawley
D005079:Excipients; D005839:Gentamicins; D005965:Glucuronates; D006017:Glycolipids; D008070:Lipopolysaccharides; D008823:Micelles; C483493:N-(1-carboxytridecyl)glucopyranuronamide